Summary

Monday, January 25, 2021

Name:
Joint Cancer - MRM Seminar
Description:
Methylation signatures that can refine the treatment paradigms for brain tumor patients
Dr. Gelareh Zadeh, M.D., Ph.D., FRCS(C), FAANS,
Professor and Dan Chair, Neurosurgery, University of Toronto;
Head, Division of Neurosurgery, Toronto Western Hospital;
Co-Director, Krembil Brain Institute, University Health Network;
Senior Scientist, Princess Margaret Cancer Research Institute;
Chair, Wilkins Family Brain Tumor Research; President, Society of Neuro-Oncology (SNO), 2020-2021; Editor-in-Chief, Neuro-Oncology Advances, Journal of SNO and EANO
Date:
Monday, January 25, 2021
Start Time:
12:00 PM
End Time:
01:00 PM
Contact Info:
Dr. Arezu Jahani-Asl (514) 340-8222 X28438 / arezu.jahani@mcgill.ca
Venue:
VIA ZOOM
 
Support research at the Lady Davis Institute - Jewish General Hospital